INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2012
Total net assets |
£128.0m |
NAV per share |
230.8p |
Share price |
207.0p |
Total value of unquoted investments |
£21.3m |
Total number of portfolio companies |
66 |
Cash |
6% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
19.91% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Aptiv |
7.7 6.8 4.4 |
Gilead |
4.1 |
Pharmaxis |
3.5 |
Alexion |
3.5 |
Insulet |
2.8 |
Onyx |
2.7 |
Jazz Life Technologies |
2.6 2.4 |
|
----------- |
Total |
40.5 |
Geographical Allocation |
% |
United States & Canada |
81 |
Europe |
9 |
Australia |
4 |
Cash |
6 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
77 |
Unquoted |
17 |
Cash |
6 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 NOVEMBER 2012